Skip to main content

UPDATE 1-Roche clears UK hurdle in $4.3 bln Spark deal, U.S. review drags on

Swiss drugmaker Roche won clearance from Britain's Competition and Markets Authority (CMA) on Monday for its planned $4.3 billion takeover of gene therapy company Spark Therapeutics, while a similar U.S. review continues.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.